1. Apoptotic Pathways and Alzheimer’s Disease: Probing Therapeutic Potential
   Vivek Kumar Sharma et al, 2021, Neurochem Res CrossRef
2. Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer’s Disease
   Manish Kumar et al, 2021, Mol Neurobiol CrossRef
3. Evaluation of involvement of adrenergic receptor modulator in hypertension induced experimental Vascular Dementia in Rats
   B.M. Sharma et al, 2021, RJPT CrossRef
4. Effectiveness of Nootropics in Combination with Cholinesterase Inhibitors on Cognitive Function in Mild-to-Moderate Dementia: A Study Using Real-World Data
   Minjae Kang et al, 2022, JCM CrossRef
5. Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs
   Matěj Malík et al, 2022, Nutrients CrossRef
6. Vascular cognitive impairment
   A.N. Bogolepova, 2022, Z. nevrol. psikhiatr. im. S.S. Korsakova CrossRef
7. Current Trends in the Animal Models for Screening of Nootropic Agents: A Systematic Review
   Shubhima Grover et al, 2023, CRCEP CrossRef
8. Apoptosis in Alzheimer’s disease: insight into the signaling pathways and therapeutic avenues
   Sneha Kumari et al, 2023, Apoptosis CrossRef
9. Blocking α1 Adrenergic Receptor as a Novel Target for Treating Alzheimer’s Disease
   Xidong Pan et al, 2024, ACS Chem. Neurosci. CrossRef
10. Integrated systems pharmacology, molecular docking, and MD simulations investigation elucidating the therapeutic mechanisms of BHD in Alzheimer’s disease treatment
    Mayank Roy Chowdhury et al, 2024, Metab Brain Dis CrossRef